Specialty Pharmacy

Global oncology trend report finds that increased use of hospital outpatient facilities shifts cost burden to patients.

Findings presented at 50th Annual Meeting of ASCO show aromatase inhibitor effective for premenopausal women when combined with ovarian function suppression.

Results from 2 large, long-term clinical trials show benefits of extended-duration treatment with tamoxifen, resulting in an update to treatment guidelines.

Stephen Vogt, PharmD, Chief Executive Officer and President of BioPlus Specialty Pharmacy, discusses the ongoing debate surrounding the high price of Hepatitis C treatments versus the efficacy of the drug.

Study assesses the safety and tolerability of TH-302 in combination with dexamethasone.

FDA updates guidelines to expedite the development and review of new drugs.

The theme of this year's meeting is "Science and Society" and will highlight the role of clinicians who treat cancer.

Pharmacists can assist patients with rheumatoid arthritis in overcoming challenges to adherence.

Jeremy Schafer, PharmD, MBA, Senior Director of Specialty Solutions and Manufacturer Relations at Prime Therapeutics, discusses new developments in medication adherence for specialty pharmacy.

Taking more than 5 medications was associated with fatigue and memory problems in multiple sclerosis patients, a new study reports.

Program offers choice and flexibility to improve the specialty patient experience and deliver superior health outcomes.

Independent Pharmacy Cooperative teams with Diplomat's retail specialty network.

The 2014 Kantar Media Pharmacy Readership Survey finds Pharmacy Times is the top choice among pharmacists, and the publication rated first in several key demographics.

Mitra Habibi, PharmD, a clinical pharmacist at the University of Illinois Hospital and Health Sciences System, discusses challenges for specialty pharmacy in the management of patients with multiple sclerosis.

Patients with HIV who smoke may be at even greater risk of developing smoking-related cancers.

Donna M. Smith, PharmD, director of clinical affairs at Avella Specialty Pharmacy discusses developments in the treatment of lung cancer that specialty pharmacies need to be aware of.

ACO focus on efficiency and quality metrics rather than pharmaceutical access cited in new survey.

Catamaran Corporation Senior Vice President of Pharmacy Operations and Industry Albert Thigpen discusses the impact from the high cost of specialty medications on overall drug spending in 2014.

Role of specialty pharmacies in treatment of multiple sclerosis discussed during annual Armada summit.

Emerging therapies and the role of specialty pharmacies in the treatment of non-small cell lung cancer were discussed during a continuing education session at the annual Armada summit.

Streamlining exon skipping drugs for other mutations will allow the company to reach over half of the Duchenne muscular dystrophy population.

CVS Caremark specialty pharmacy executive discusses the evolution of a patient-centered health care ecosystem.

CVS/pharmacy first to seek community pharmacy accreditation.

The cost of specialty drugs is driving increases in overall unit cost, according to an annual Catamaran Corporation report.

Study finds progeria treatment to extend survival time by 1.6 years.

Opexa Therapeutics is initiating a phase IIb trial of a novel therapy that targets T-cells in patients with secondary progressive multiple sclerosis.

Author and consultant Myrtle Potter told attendees of the Armada Specialty Pharmacy Summit that specialty pharmacies need to demonstrate their value to capitalize on the changing health care environment.

An analysis of several phase III clinical trials suggests that health-related quality-of-life scores decrease less when patients receive sofosbuvir therapy than interferon therapy.

The cooperative meeting of CMSC and ACTRIMS in Dallas platforms latest treatment, research and resources for MS health care professionals.